top of page
AdobeStock_456930385_edited.jpg

Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease.

JANUARY 24

Phase I study underway as first volunteer dosed with VES001, a first-in-class oral treatment for Frontotemporal Dementia.

DECEMBER 23

bottom of page